(Press-News.org) Barcelona, 18 August 2014. Research led by the Vall d'Hebron Institute of Oncology (VHIO) evidence the most conclusive preclinical results to-date validating Myc inhibition as a therapeutic strategy in glioma – a highly agressive tumor type that notoriously outsmarts current anti-cancer therapies. The study led by Laura Soucek, Principal Investigator of VHIO´s Mouse Models of Cancer Therapies Group, published today in Nature Communications, not only represents an important step forward in ultimately providing brain glioma patients with new therapeutic avenues, but also reveals new insights into the biology of Myc that could further impact on its therapeutic potential.
In a study published last year, the group succeded in eradicating lung tumors in transgenic mice by adopting the same strategy involving the expression of Omomyc, a Myc inhibitor designed by Soucek. They also confirmed that there were no side effects post-administration of repeated and long-term treatment. Importantly, there was no evidence of resistance to therapy -- one of the greatest challenges in the treatment of cancer. These results therefore confirmed Myc inhibition as a sound and effective therapeutic strategy for the development of novel cancer drugs.
Soucek and her group were to raise the bar yet higher. Firstly, the focus on gene expression-based therapy under experimental study progressed and re-programed on the development of an administrable Omomyc-based drug. Second, the group continued to show the efficacy of Myc inhibition across different tumors and, above and beyond transgenic models, they showed the same success in human tumors using a technique that transfers human cancer cells to immunodeficient mice. "Upon reporting initial results at preclinical level, our main concern was how do demonstrate these findings in human tumors," says Laura Soucek. "Firstly, we focused on how they could apply to other tissues and other more aggressive tumor types for which there are no effective treatments, whereby an ´Omomyc solution´ could make all the difference. We also aimed to reveal new insights into the mechanism of action of Omomyc in tumor cells." It seems that Soucek's group has now found answers to all these questions. "All our efforts must now concentrate on finding a means for its pharmacological administration. Based on our research currently underway, we have every reason to be optimistic" asserts Soucek.
A novel therapy for the most common and aggressive brain tumor
After four years´ exhaustive research, these latest results bring more good news and with them, preclinical Myc inhibition has also been validated as a therapeutic strategy against astrocytoma, a type of glioma, in vivo in mouse models and in vitro in stem cells of these tumors. In these models, which develop advanced brain tumors with clear neurological symptoms, treatment with the Omomyc transgene drastically reduces tumors and improves the associated symptoms until the mouse recovers and starts to act completely normally. Mice treated with Omomyc survived, whereas those without, did not. "We did not stop there," explains Soucek, "we applied therapy with Omomyc to both human glioblastoma cell lines and mice with patient-derived tumor xenografts that faithfully recapitulate human tumors." The therapeutic impact of Omomyc lies in its structure, which is similar to that of Myc, making it possible to block the transcription of genes controlled by this protein. Myc inhibition leads to "defects" in tumor cells and often results in their death by inducing mitotic aberrations, thus halting normal cell division.
"Our results undoubtedly show that Myc inhibition is effective in mouse tumors and, more notably, in human glioma." she explains. The group has demonstrated the additional therapeutic potential of Omomyc thanks to their clinically orientated approach aimed against the most common and aggressive primary tumor to affect the adult central nervous system – glioblastoma, for which there is a critical call to improve current therapies which are largely ineffective. "This is the very first time that the use of Omomyc in human tumor specimens have been validated. We have also confirmed that Myc inhibition is effective against the tumor once it has developed, acts against tumor initiating cells, and prevents them from dividing, proliferating and forming the tumor again." continues Dr. Soucek.
Mitotic catastrophe as the therapeutic mechanism of Myc inhibition
The Myc protein plays an important role in regulating gene transcription, controlling the expression of up to 15% of human genes. It is also implicated in cellular proliferation, differentiation and apoptosis (programmed cell death which is necessary for tissue regeneration and the elimination of damaged cells). However, alterations in this protein trigger uncontrolled cell proliferation, which can result in cancers developing in different tissues. Myc deregulation is actually found in most tumors including cancer of the cervix, breast, colon, lung, pancreas, and stomach.
Brain tumors can now be added to this list of potential tumors that can be targeted with Myc inhibition.
At the cellular level, we now know more about its mechanism of action. Regardless of the experimental system used, Myc inhibition reduces proliferation and increases cell death. "Importantly, the cells we treated with Omomyc went crazy. They showed problems with cell proliferation, with aberrant mitosis and the formation of cells with many nuclei that then died through mitotic catastrophe, that is, due to the inability to divide properly" explains Laura Soucek. "If we do not allow Myc to function normally, tumor cells cannot divide efficiently." she affirms. Myc is not deregulated in healthy cells, hence, its inhibition does not generate any significant side effects that might limit the use of this therapy.
To conclude, Myc inhibition as a therapeutic strategy against brain tumors opens up new avenues signposting fresh hope and improved, more effective therapies for patients. Soucek and her team are consequently concentrating on translating their findings to the clinic. Preliminary results show promise.
INFORMATION: END
Myc inhibition is an effective therapeutic strategy against most aggressive brain tumors
Latest research at VHIO validates Myc inhibition as an effective therapeutic strategy against brain tumors
2014-08-18
ELSE PRESS RELEASES FROM THIS DATE:
Sun's activity influences natural climate change
2014-08-18
For the first time, a research team has been able to reconstruct the solar activity at the end of the last ice age, around 20,000-10,000 years ago, by analysing trace elements in ice cores in Greenland and cave formations from China. During the last glacial maximum, Sweden was covered in a thick ice sheet that stretched all the way down to northern Germany and sea levels were more than 100 metres lower than they are today, because the water was frozen in the extensive ice caps. The new study shows that the sun's variation influences the climate in a similar way regardless ...
Antibiotics in early life may alter immunity long-term
2014-08-18
New University of British Columbia research found that receiving antibiotic treatments early in life can increase susceptibility to specific diseases later on.
Most bacteria living in the gut play a positive role in promoting a healthy immune system, but antibiotic treatments often do not discriminate between good and bad bacteria. The study published today in Journal of Allergy and Clinical Immunology helps scientists understand how different antibiotics affect good bacteria.
"This is the first step to understanding which bacteria are absolutely necessary to develop ...
Promising ferroelectric materials suffer from unexpected electric polarizations
2014-08-18
UPTON, NY—Electronic devices with unprecedented efficiency and data storage may someday run on ferroelectrics—remarkable materials that use built-in electric polarizations to read and write digital information, outperforming the magnets inside most popular data-driven technology. But ferroelectrics must first overcome a few key stumbling blocks, including a curious habit of "forgetting" stored data.
Now, scientists at the U.S. Department of Energy's Brookhaven National Laboratory have discovered nanoscale asymmetries and charge preferences hidden within ferroelectrics ...
International scientific team criticizes adoption of 'novel ecosystems' by policymakers
2014-08-18
Embracing "novel" ecosystems is dangerous, according to a new study by an international team.
Novel ecosystems arise when human activities transform biological communities through species invasions and environmental change. They are seemingly ubiquitous, and thus many policymakers and ecologists argue for them to be accepted as the "new normal"—an idea the researchers say is a bad one.
In the study, published in the September edition of the academic journal Trends in Ecology and Evolution, the international team argues that adopting novel ecosystems is based on faulty, ...
Visual 'gist' helps us figure out where a crowd is looking
2014-08-18
Have you ever seen a crowd of people looking off into the distance, perhaps toward a passing biker or up to the top of a building? There's a good chance you looked there, too, instantly, even without paying attention to the individuals in the group. How can we tell where a crowd is looking with so little effort?
Researchers at the University of California, Berkeley and the University of Denver have discovered that we rely on a specialized visual process known as "ensemble coding" to perceive where a crowd is looking. Their new study shows that we are able to tell where ...
Prioritizing suicide research can help lead to fewer suicide attempts and deaths
2014-08-18
Ann Arbor, MI, August 18, 2014 – In a new supplement to the September issue of the American Journal of Preventive Medicine, experts address the state of the science on suicide prevention and provide useful recommendations for research to inform effective suicide prevention. Suicide has been a challenging and perplexing public health issue to study as it has many dimensions and underlying factors. Although much is known about the patterns and potential risk factors of suicide, the national suicide rate does not appear to have dropped over the last 50 years.
This groundbreaking ...
IU study: Parents' vaccine intentions influenced by how benefits are communicated
2014-08-18
INDIANAPOLIS -- How do parents decide whether to vaccinate their child? In a study designed to formally look at the content of parent-targeted communications about the benefits of vaccination for measles, mumps and rubella, Indiana University School of Medicine investigators report that the framing of these messages influences parents' intentions to immunize their children.
The investigators report that parents who viewed informational material highlighting direct benefits to their own child were the most likely to subsequently indicate that they would have their baby ...
White, straight women leading surge in infertility treatments
2014-08-18
WASHINGTON — Heterosexual white women are twice as likely as racial or sexual minority women to obtain medical help to get pregnant, according to a recent study published by the American Psychological Association.
While income and lack of insurance only partially explained the lower number of racial minority women receiving fertility assistance, lack of insurance appeared to play a crucial role in whether lesbian and bisexual women received medical fertility help, especially in more recent years, according to the nationally representative study published in the APA journal ...
Environment and health experts commit to actions on climate change
2014-08-18
MONTREAL, August 15, 2014 — More than 500 delegates to the EcoHealth 2014 conference have issued a call to action to urgently and collaboratively address the impacts of climate change on the health of humans, animals and the global environment in light of the lack of a truly collective response to date.
Working through the International Association for Ecology and Health (IAEH), the 500 delegates from 62 countries, and the larger ecohealth community they reflect, have developed a vision and commitment to action that will bring together what is already being done to address ...
Stronger drunk driving laws lead to safer roads: Study
2014-08-18
Changes to British Columbia's laws against driving while impaired have reduced fatal crashes as well as ambulance calls and hospital admissions resulting from motor vehicle crashes, a new University of British Columbia study finds.
Researchers concluded that harsher penalties for impaired driving and speeding instituted by the B.C. government in September 2010 reduced crashes related to drinking and driving.
Automobile crashes declined 21 per cent, crash-related hospital admissions dropped 8 per cent and crash-related ambulance calls fell by 7.2 per cent. Based on ...
LAST 30 PRESS RELEASES:
New strategies to enhance chiral optical signals unveiled
Cambridge research uncovers powerful virtual reality treatment for speech anxiety
2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research
International survey finds that support for climate interventions is tied to being hopeful and worried about climate change
Cambridge scientist launches free VR platform that eliminates the fear of public speaking
Open-Source AI matches top proprietary model in solving tough medical cases
Good fences make good neighbors (with carnivores)
NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer
Introducing our new cohort of AGA Future Leaders
Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help
Engineering excellence: Engineers with ONR ties elected to renowned scientific academy
New CRISPR-based diagnostic test detects pathogens in blood without amplification
Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer
Growing solar: Optimizing agrivoltaic systems for crops and clean energy
Scientists discover how to reactivate cancer’s molecular “kill switch”
YouTube influencers: gaming’s best friend or worst enemy?
uOttawa scientists use light to unlock secret of atoms
NJIT mathematician to help map Earth's last frontier with Navy grant
NASA atmospheric wave-studying mission releases data from first 3,000 orbits
‘Microlightning’ in water droplets may have sparked life on Earth
Smoke from wildland-urban interface fires more deadly than remote wildfires
What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood
Protein accidentally lassos itself, helping explain unusual refolding behavior
With bird flu in raw milk, many in U.S. still do not know risks of consuming it
University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease
UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS
Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it
A closer look at biomolecular ‘silly putty’
Oxytocin system of breastfeeding affected in mothers with postnatal depression
Liquid metal-enabled synergetic cooling and charging: a leap forward for electric vehicles
[Press-News.org] Myc inhibition is an effective therapeutic strategy against most aggressive brain tumorsLatest research at VHIO validates Myc inhibition as an effective therapeutic strategy against brain tumors